Psyched wellness announces changes to the board of
directors
Toronto,
Ontario, March 15, 2021 – Psyched Wellness Ltd.
(CSE:PSYC, OTCQB:PSYCF, FRANKFURT:5U9) (the "Company"
or "Psyched")
a life sciences company focused on the production and distribution of
artisanal functional and psychedelic mushrooms, is pleased
to announce that Janeen Stodulski
has been appointed as a director of the Corporation.
Psyched also
announced that Chris Hazleton has resigned as a director of the
Corporation. CEO Jeff Stevens commented that, "Chris
stayed on as one of the legacy
directors from Duncan Park Holdings
to ensure a smooth
transition as Psyched went public. We appreciate his time and
effort and wish him well with his future endeavors."
Ms.
Stodulski
A graduate of Brock
University, Janeen received her CPA designation in 1999 and her MBA
from Queen's University in 2002 and most recently completed her
In-Depth taxation with CPA Canada.
Janeen brings more
than 30 years in diverse tax, financial, and business consulting
experience to the table. She has gained extensive accounting
experience through her senior roles in public practice, as a
partner at MNP and Client Service Manager at Grant Thornton LLP as
well as several board positions and
C-suite roles in a
variety of companies. Janeen extensive expertise allows her to
provide outside the box strategies and solutions in addition to
comprehensive accounting services.
Ms. Stodulski has
received numerous awards and appointments during her career,
including an appointment to the Prime Minister's Task Force on
Women Entrepreneurs, Ontario and Chapter Distinguished Service
awards with CGA, Royal Bank Women Entrepreneurs finalist and
Oakville Community Environmental Award.
"I am thrilled to
welcome Janeen to the board and know that her experience and
passion for this role will add tremendous value to the team and
Psyched shareholders," says Jeff Stevens CEO of the
Company.
In connections with
Ms. Stodulski joining the board she will be issued 500,000 options
subject to board and exchange approvals. In addition to Ms.
Stodulski option issuance, 1.5M options will be allocated to
various consultants for their efforts.
The Company also
wishes to disclose that it has engaged the services of the
following groups:
Stockhouse
Publishing
Ltd.,
for a
12-month
contract totaling
$100K
Proactive
Media PRO
for a
12-month
contract
totaling $49,500.
For further
information, please contact:
Jeffrey
Stevens
Chief Executive
Officer
Psyched Wellness
Ltd.
Tel:
647-400-8494
Email:
jstevens@psyched-wellness.com
Website:
http://www.psyched-wellness.com
For media
relations, please contact:
Anne
Graf
KCSA Strategic
Communications
agraf@kcsa.com
786-390-2644
Neither the
Canadian Securities Exchange nor its Regulation Services Provider
have reviewed or accept responsibility for the adequacy or accuracy
of this release.
About Psyched
Wellness Ltd.:
Psyched Wellness
Ltd. is a Canadian-based health supplements company dedicated to
the distribution of mushroom-derived products and associated
consumer packaged goods. The Company's objective is to create
premium mushroom-derived products that have the potential to become
a leading North American brand in the emerging functional food
category. The Company is in the process of developing a line
of Amanita muscaria-derived water-based extracts, teas and capsules
designed to help with three health objectives: promote stress
relief, relaxation and assist with restful
sleeping.
Cautionary
Statement Regarding Forward Looking Information and
Statements
This press
release contains 'forward-looking information' within the meaning
of applicable Canadian securities legislation. These statements
relate to future events or future performance. The use of any of
the words "could", "intend", "expect", "believe", "will",
"projected", "estimated" and similar expressions and statements
relating to matters that are not historical facts are intended to
identify forward-looking information and are based on Psyched
Wellness Ltd. current belief or assumptions as to the outcome and
timing of such future events. Forward-looking information is based
on reasonable assumptions that have been made by Psyched at the
date of the information and is subject to known and unknown risks,
uncertainties, and other factors that may cause actual results or
events to differ materially from those anticipated in the
forward-looking information, including, without limitation,
(i)
the accuracy of the Toxicology Assessment, (ii) the safety of
Amanita Muscaria
consumption and the safety and purity of any extracts thereof, and
(iii) the uses and potential benefits of Amanita
Muscaria. Given
these risks, uncertainties, and assumptions, you should not unduly
rely on these forward-looking statements. The forward-looking
information contained in this press release is made as of the date
hereof, and Psyched is not obligated to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise, except as required by
applicable securities laws. The foregoing statements expressly
qualify any forward-looking information contained herein. Factors
that could cause actual results to differ materially from those
anticipated in these forward-looking statements are described under
the caption "Risk Factors" in Psyched Wellness Ltd.
management's discussion and analysis for the six months ended May
31, 2020 and covering the subsequent period up to July 27, 2020
("MD&A"), dated July 27, 2020, which is available on Psyched
Wellness Ltd. profile at www.sedar.com.
This news
release does not constitute an offer to sell or the solicitation of
an offer to buy, and shall not constitute an offer, solicitation or
sale in any state, province, territory or jurisdiction in which
such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state, province, territory or jurisdiction.
This news
release includes data that has been obtained from third party
sources, including the findings from the Toxicology Assessment. The
Company believes that the data is accurate and that its estimates
and assumptions are reasonable, but there is no assurance as to the
accuracy or completeness of this data. Third party sources
generally state that the information contained therein has been
obtained from sources believed to be reliable, but there is no
assurance as to the accuracy or completeness of included
information. Although the data is believed to be reliable, the
Company has not independently verified any of the data from third
party sources referred to in this news release or ascertained the
underlying assumptions relied upon by such sources.
